MRPS6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.7770008514949E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.63430380339946E-11 |
Normal-vs-Stage2 |
2.12210027328297E-10 |
Normal-vs-Stage3 |
3.78149733748501E-11 |
Normal-vs-Stage4 |
5.23270315966329E-11 |
Stage1-vs-Stage2 |
1.144430E-01 |
Stage1-vs-Stage3 |
4.709800E-01 |
Stage1-vs-Stage4 |
2.382200E-01 |
Stage2-vs-Stage3 |
2.908200E-01 |
Stage2-vs-Stage4 |
4.010400E-01 |
Stage3-vs-Stage4 |
7.237600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.75539599417607E-11 |
Normal-vs-AfricanAmerican |
7.83262343873048E-12 |
Normal-vs-Asian |
7.14794889944415E-12 |
Caucasian-vs-AfricanAmerican |
4.812100E-02 |
Caucasian-vs-Asian |
8.252200E-02 |
AfricanAmerican-vs-Asian |
5.672000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.27530249985853E-11 |
Normal-vs-Female |
5.855538276478E-12 |
Male-vs-Female |
1.741900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.59632332194815E-12 |
Normal-vs-Age(41-60Yrs) |
2.14119832975257E-11 |
Normal-vs-Age(61-80Yrs) |
4.44250192188633E-11 |
Normal-vs-Age(81-100Yrs) |
1.83299999623188E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.145370E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.095600E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.400750E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.875200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.068000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.613000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.08897393511643E-12 |
Normal-vs-Grade 2 |
7.84017295529793E-12 |
Normal-vs-Grade 3 |
6.49349463088811E-11 |
Normal-vs-Grade 4 |
5.64030044891695E-10 |
Grade 1-vs-Grade 2 |
5.653400E-01 |
Grade 1-vs-Grade 3 |
1.894170E-01 |
Grade 1-vs-Grade 4 |
4.246200E-02 |
Grade 2-vs-Grade 3 |
3.881900E-03 |
Grade 2-vs-Grade 4 |
2.678200E-02 |
Grade 3-vs-Grade 4 |
4.189800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.74225128452599E-12 |
Normal-vs-ccB subtype |
5.12170306166126E-11 |
ccA subtype-vs-ccB subtype |
4.616000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.68549618706493E-11 |
Normal-vs-N1 |
3.61550012151213E-10 |
N0-vs-N1 |
8.128800E-01 |
|
|